PATENT CLAIM ANALYSIS

Application Number: 16179174
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "256000"]

Abstract:
The present invention is directed to novel protein kinase inhibitors comprising the chemical compound N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(3-hydroxypyrrolidin-1-yl)pyrimidin-4-yl]amino]thiazole-5-carboxamide, its pharmaceutically acceptable salts, enantiomers, and enantiomeric mixtures, and methods of use to treat protein kinase-mediated diseases or conditions.

Claim (Index 16):
A method of treating a subject suffering from cancer, comprising administering to the subject suffering from cancer a therapeutically effective amount of a compound having the structure and/or salt thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15839469', '15839332', '13403394', '13971793', '14521766']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7323494999115059
- 35 USC 102 Novelty (BERT): 0.5546307930673475
- Combined Prediction Score: 0.7145776292270901
- Mean Citation Score: 357.999914
- Max Citation Score: 434.35107
- Similarity Product: 284.5680273905647

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test